Address: 301 A-Leela Business Park,M.V. Road, Andheri
Tel: +91 22 5677 4242
Quintiles Transnational is a pharmaceutical services company offering clinical, commercial, consulting and capital services. The Quintiles network consists of more than 20,000 employees in 60 countries.
Quintiles manages clinical trials on behalf of pharmaceutical customers, and provides the following services:
Management of clinical trials, data, projects and providing laboratory services
Providing customers with sales force, product and brand solutions.
Providing data-driven recommendations to help customers achieve success.
Creating strategic partnerships through financing and operational solutions.
Quintiles India is located amidst a rapidly growing local pharmaceutical market. With five offices spread across the country, we help clients take advantage of a well-established corporate infrastructure, government policies favoring R&D, growth in the health insurance sector, and tertiary care and teaching hospitals available for trials.
Other advantages: Quintiles India has solid relationships with leading medical centers and experienced English-speaking investigators. All studies are conducted to FDA and ICH GCP standards. Urban India’s literate population provides fast, efficient access to broad population groups with common and special disease profiles, allowing for rapid patient recruitment and faster study start-ups.
Quintiles helped develop or commercialize all of 2009’s top 50 best selling drugs or compounds and nearly 90% of all breakthrough products released on the market between 1996 and 2008.
Key Services in India:
Access to patients
Central laboratory services
Clinical monitoring and site management
Data management offering a functional service provider (FSP) business model
ECG monitoring services
Access through Our India Team to Quintiles Worldwide:
Ashok Battacharya, executive director of the Indian affiliate of Takeda Pharmaceuticals, with 38 years experience…
Think global, act local! This is the Novartis business approach in India. A great believer in stakeholder…
Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven…
Alexandre Williams, founder and managing director of Athena, an international company with an Indian manufacturing…
As the founder and chairman of Alves Group, a key Indian player in medical devices with an extensive portfolio,…
Dharmesh Shah, managing director of BDR Pharmaceuticals, a company with a strong expertise in oncology, intensive…
For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India…
Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to…
Nikhil Masurkar, executive director of Entod Pharmaceuticals, talks about the company’s ambition to invest in…
Manni Kantipudi, CEO of GVK BIO, talks about the evolution of the company, which he took from USD 20 million to its…
R.S. Subramanian, country manager and Sandeep Juneja, vice president – Sales and Marketing, DHL Express India,…